B-Cell Depletion, Remissions of Malignancy, and Cytokine-Associated Toxicity in a Clinical Trial of T Cells Genetically-Engineered to Express An Anti-CD19 Chimeric Antigen Receptor
Autor: | Kochenderfer, James N, Dudley, Mark E. *, Feldman, Steven *, Wilson, Wyndham H., Spaner, David *, Devillier, Laura *, Carpenter, Robert *, Nathan, Debbie-Ann N. *, Maric, Irina *, Morgan, Richard A. *, Rosenberg, Steven A. * |
---|---|
Zdroj: | In Blood 18 November 2011 118(21):167-167 |
Databáze: | ScienceDirect |
Externí odkaz: |